Loading
Latest filing published 21 Jan 2016 for CASI Pharmaceuticals, Inc.. Read the official filing
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
This profile gathers the share dealings of Ken Ren in CASI Pharmaceuticals, Inc. In total, 4 filings cover trades dated 19 January 2016.
Purchases make up the whole of the open-market record (4 purchases). The totals exclude 4 filings filed without an amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
None of the 4 purchases we analysed coincided with buying by another insider of the same company within 30 days.
The newest entry dates from 21 January 2016: an open-market purchase, in CASI Pharmaceuticals, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations